Acasti Pharma Operating Expenses 2011-2026 | ACST

Annual Operating Expenses Acasti Pharma

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	24.4 M	-	-	-	7.06 M	9.93 M	9.89 M	7.13 M	6.67 M	2.47 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
24.4 M	2.47 M	9.66 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Adaptimmune Therapeutics plc ADAP	141 M	-	-15.15 %	$ 60.3 M	Britain
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Aptorum Group Limited APM	20.7 M	$ 0.83	2.17 %	$ 4.53 M	China
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
BioNTech SE BNTX	512 M	$ 110.14	3.3 %	$ 27.2 B	Germany
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.51	-0.52 %	$ 8.45 B	Australia
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 4.21	1.2 %	$ 9.16 B	Israel
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	209 M	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	167 M	$ 1.49	7.19 %	$ 279 M	USA
Aptose Biosciences APTO	26.3 M	-	-45.71 %	$ 1.2 M	Canada
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Ascendis Pharma A/S ASND	338 M	$ 221.8	-0.16 %	$ 5 B	Danmark
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Aridis Pharmaceuticals ARDS	23.4 K	-	17.91 %	$ 11.1 M	USA
Burford Capital Limited BUR	106 M	$ 8.96	0.45 %	$ 1.41 B	Britain
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
Athersys ATHX	79.8 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	145 M	$ 1.46	2.46 %	$ 373 M	Britain
Amneal Pharmaceuticals AMRX	539 M	$ 14.49	-0.24 %	$ 4.48 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	53.7 M	$ 2.35	-1.81 %	$ 14.8 M	USA
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Brickell Biotech BBI	14.4 M	-	-5.38 %	$ 6.06 M	USA